Glycogen synthase kinase-3β is associated with the prognosis of hepatocellular carcinoma and may mediate the influence of type 2 diabetes mellitus on hepatocellular carcinoma.

Glycogen synthase kinase-3β is associated with the prognosis of hepatocellular carcinoma and may mediate the influence of type 2 diabetes mellitus on hepatocellular carcinoma.
复制标题

DOI:
10.1371/journal.pone.0105624
复制
发表时间:
2014
期刊:
影响因子:
3.7
通讯作者:
Shen F
Shen F
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Qiao G;Le Y;Li J;Wang L;Shen F

文献摘要

参考文献

被引文献

相似文献

尽管许多研究表明糖原合成酶激酶-3 β(glycogen synthase kinase-3 β,GSK-3β)与2型糖尿病(type 2 diabetes mellitus,T2 DM)及多种肿瘤有关,但GSK-3β在肝细胞癌(hepatocellular carcinoma,HCC)中的作用以及GSK-3β与T2 DM和HCC之间的相关性尚不清楚。本研究旨在探讨p-Ser 9-GSK-3β对肝癌患者预后的影响,并进一步了解T2 DM、GSK-3β与肝癌预后之间的相互作用。首先采用逆转录聚合酶链反应(RT-PCR)和蛋白质印迹法检测GSK-3β和p-Ser 9-GSK-3β在肝癌组织中的表达水平。然后,我们使用免疫组化染色来评估p-Ser 9-GSK-3β在178例肝癌根治性部分肝切除术后的表达模式。最后统计分析p-Ser 9-GSK-3β与T2 DM与HCC患者预后的关系。P-Ser 9-GSK-3β在肿瘤组织中的表达高于正常组织。相关和回归分析显示p-Ser 9-GSK-3β过表达与2型糖尿病的发生显著相关,相关系数为0.259(P = 0.001)。  多因素分析显示,p-Ser 9-GSK-3β的过度表达(P<0.001)和T2 DM(P = 0.008)分别是HCC预后不良的独立相关因素。  进一步的分析表明,这两个变量是密切相关的。p-Ser 9-GSK-3β过表达和T2 DM与HCC手术预后差密切相关。P-Ser 9-GSK-3β可能在T2 DM影响HCC预后中起重要作用。
Although many studies have shown glycogen synthase kinase-3β(GSK-3β) was associated with type 2 diabetes mellitus(T2DM) and implicated with a wide range of cancers, the role of GSK-3β in hepatocellular carcinoma(HCC) and the correlation among GSK-3β, T2DM and HCC remains unclear. Our objectives were to identify the effect of p-Ser9-GSK-3β on the prognosis of patients with HCC and to learn more about the interaction among T2DM, GSK-3β and the prognosis of HCC. Firstly we used reverse transcriptase-PCR(RT-PCR) and western blotting to determine the expression levels of GSK-3β and p-Ser9-GSK-3β in human HCC samples. We then used immunohistochemical staining to evaluate the expression pattern of p-Ser9-GSK-3β in 178 patients with HCC after curative partial hepatectomy. Finally we statistically analyzed the association of p-Ser9-GSK-3β and T2DM with the prognosis of patients with HCC. P-Ser9-GSK-3β was over-expressed in tumor tissues compared with their normal counterparts. Correlation and regression analysis indicated that the over-expression of p-Ser9-GSK-3β was significantly associated with T2DM, and the correlation coefficient was 0.259 (P = 0.001). Multivariate analysis showed that the over-expression of p-Ser9-GSK-3β(P<0.001) and T2DM(P = 0.008) were independently associated with poor prognosis of HCC, respectively. Further analysis demonstrated that these two variables are closely related with each other. The over-expression of p-Ser9-GSK-3β and T2DM are strongly correlated with worse surgical outcome of HCC. P-Ser9-GSK-3β may play a significant role in mediating the influence of T2DM on the prognosis of HCC.
DOI: 10.1158/1078-0432.ccr-08-0760
发表时间: 2009-02-01
影响因子: 11.5
作者:
Miyashita, Katsuyoshi;Kawakami, Kazuyuki;Minamoto, Toshinari
通讯作者: Minamoto, Toshinari
DOI: 10.1038/bjc.1992.65
发表时间: 1992-03
影响因子: 8.8
作者:
Macaulay, V M
通讯作者: Macaulay, V M
DOI: 10.1016/s0002-9440(10)62058-5
发表时间: 2005-09-01
影响因子: 6
作者:
Boissan, M;Beurel, E;Desbois-Mouthon, C
通讯作者: Desbois-Mouthon, C
DOI: 10.1158/1078-0432.ccr-06-0196
发表时间: 2006-09-01
影响因子: 11.5
作者:
Ougolkov, Andrei V.;Fernandez-Zapico, Martin E.;Billadeau, Daniel D.
通讯作者: Billadeau, Daniel D.
DOI: 10.1016/s0304-3835(03)00421-x
发表时间: 2003-09-25
期刊: CANCER LETTERS
影响因子: 9.7
作者:
Ban, KC;Singh, H;Seow, HF
通讯作者: Seow, HF